Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
Add more filters










Publication year range
1.
Mol Med Rep ; 14(4): 2937-44, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27573915

ABSTRACT

The present study investigated the photoprotective properties of the ethyl acetate fraction of Sargassum muticum (SME) against ultraviolet B (UVB)­induced skin damage and photoaging in a mouse model. HR­1 strain hairless male mice were divided into three groups: An untreated control group, a UVB­irradiated vehicle group and a UVB­irradiated SME group. The UVB­irradiated mice in the SME group were orally administered with SME (100 mg/kg body weight in 0.1 ml water per day) and then exposed to radiation at a dose of 60­120 mJ/cm2. Wrinkle formation and skin damage were evaluated by analysis of skin replicas, epidermal thickness and collagen fiber integrity in the dermal connective tissue. The mechanism underlying the action of SME was also investigated in the human HaCaT keratinocyte cell line following exposure of the cells to UVB at a dose of 30 mJ/cm2. The protein expression levels and activity of matrix metalloproteinase­1 (MMP­1), and the binding of activator protein­1 (AP­1) to the MMP­1 promoter were assessed in the HaCaT cells using western blot analysis, an MMP­1 fluorescent assay and a chromatin immune­precipitation assay, respectively. The results showed that the mean length and depth of the wrinkles in the UVB­exposed hairless mice were significantly improved by oral administration of SME, which also prevented the increase in epidermal thickness triggered by UVB irradiation. Furthermore, a marked increase in collagen bundle formation was observed in the UVB­treated mice with SME administration. SME pretreatment also significantly inhibited the UVB­induced upregulation in the expression and activity of MMP­1 in the cultured HaCaT keratinocytes, and the UVB­enhanced association of AP­1 with the MMP­1 promoter. These results suggested that SME may be useful as an anti-photoaging resource for the skin.


Subject(s)
Keratinocytes/drug effects , Keratinocytes/radiation effects , Plant Extracts/pharmacology , Radiation-Protective Agents/pharmacology , Sargassum/chemistry , Skin Aging/drug effects , Skin Aging/radiation effects , Acetates/chemistry , Acetates/pharmacology , Animals , Cell Line , Humans , Keratinocytes/cytology , Male , Mice, Hairless , Plant Extracts/chemistry , Radiation-Protective Agents/chemistry , Skin/cytology , Skin/drug effects , Skin/radiation effects , Ultraviolet Rays
2.
Biol Pharm Bull ; 39(8): 1273-83, 2016.
Article in English | MEDLINE | ID: mdl-27476937

ABSTRACT

This study was conducted to evaluate the effects of Sargassum muticum extract and apo-9'-fucoxanthinone, a principal component of S. muticum, on hair growth. When rat vibrissa follicles were treated with S. muticum extract for 21 d, the hair-fiber lengths for the vibrissa follicles increased significantly. Treatment with the S. muticum extract and the EtOAc fraction of the S. muticum extract markedly increased the proliferation of dermal papilla cells (DPCs) and decreased the 5α-reductase activity. In addition, the EtOAc fraction of the S. muticum extract significantly promoted anagen initiation in C57BL/6 mice. Especially, apo-9'-fucoxanthinone, an active constituent from the S. muticum extract, caused an increase in DPC proliferation and a decrease in 5α-reductase activity. To elucidate the molecular mechanisms of apo-9'-fucoxanthinone on the proliferation of DPCs, we examined the level of various signaling proteins. Apo-9'-fucoxanthinone increased the level of vascular endothelial growth factor receptor-2 (VEGF-R2), Wnt/ß-catenin signaling proteins such as phospho(ser9)-glycogen synthase kinase-3ß (GSK-3ß) and phospho(ser552)-ß-catenin, whereas apo-9'-fucoxanthinone did not affect the transforming growth factor-ß (TGF-ß) signaling proteins such as Smad2/3. These results suggest that apo-9'-fucoxanthinone from S. muticum could have the potential for hair growth with DPC proliferation via the activation of Wnt/ß-catenin signaling and the VEGF-R2 pathway.


Subject(s)
5-alpha Reductase Inhibitors/pharmacology , Hair/drug effects , Sargassum , Terpenes/pharmacology , Animals , Cell Proliferation/drug effects , Cholestenone 5 alpha-Reductase/metabolism , Complex Mixtures/pharmacology , Female , Hair/cytology , Hair/growth & development , Hair/metabolism , Male , Mice, Inbred C57BL , Prostate/drug effects , Prostate/enzymology , Rats, Sprague-Dawley , Rats, Wistar , Transforming Growth Factor beta/metabolism , Vascular Endothelial Growth Factor Receptor-2/metabolism , Wnt Signaling Pathway/drug effects , beta Catenin/metabolism
3.
J Environ Pathol Toxicol Oncol ; 35(1): 11-28, 2016.
Article in English | MEDLINE | ID: mdl-27279581

ABSTRACT

Natural marine products show various biological properties such as antiphotoaging, antioxidant, anticancer, and anti-inflammation. This study evaluated the protective effects of the brown alga Carpomitra costata (Stackhouse) Batters (Sporochnaceae) against ultraviolet B (UVB)-provoked damage in human HaCaT keratinocytes. C. costata extract (CCE) effectively reduced superoxide anion, hydroxyl radical, and UVB-stimulated intracellular reactive oxygen species (ROS) levels. CCE also restored the expression and activity of UVB-suppressed antioxidant enzymes. Furthermore, CCE decreased UVB-triggered oxidative damage to cellular components including DNA, protein, and lipid and defended the cells against mitochondrial membrane depolarization-medicated apoptosis. The results of this study indicate that CCE can safeguard human keratinocytes against UVB-induced cellular damage via a potent antioxidant mechanism. CCE may find utility as part of a therapeutic arsenal against the damaging effects of UVB radiation on the skin.


Subject(s)
Antioxidants/metabolism , Keratinocytes/drug effects , Keratinocytes/radiation effects , Phaeophyceae/chemistry , Plant Extracts/pharmacology , Skin Aging/drug effects , Ultraviolet Rays , Humans
4.
Toxicol Res ; 32(2): 109-14, 2016 Apr.
Article in English | MEDLINE | ID: mdl-27123161

ABSTRACT

Allergic skin inflammation such as atopic dermatitis is characterized by skin barrier dysfunction, edema, and infiltration with various inflammatory cells. The anti-inflammatory effects of Apo-9'-fucoxanthinone, isolated from Sargassum muticum, have been described in many diseases, but the mechanism by which it modulates the immune system is poorly understood. In this study, the ability of Apo-9'-fucoxanthinone to suppress allergic reactions was investigated using a mouse model of atopic dermatitis. The Apo-9'-fucoxanthinone-treated group showed significantly decreased immunoglobulin E in serum. Also, Apo-9'-fucoxanthinone treatment resulted in a smaller lymph node size with reduced the thickness and length compared to the induction group. In addition, Apo-9'-fucoxanthinone inhibited the expression of interleukin-4, interferon-gamma and tumor necrosis factor-alpha by phorbol 12-myristate 13-acetate and ionomycin-stimulated lymphocytes. These results suggest that Apo-9'-fucoxanthinone may be a useful therapeutic strategy for treating chronic inflammatory diseases.

5.
Environ Toxicol Pharmacol ; 43: 112-9, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26991844

ABSTRACT

The aim of this study was to evaluate the photo-preventive effects of sargachromenol (SC) against ultraviolet B (UVB)-induced oxidative stress in human keratinocytes via assessing the antioxidant properties and underlying molecular mechanisms. SC exhibited a significant scavenging effect on UVB-induced intracellular reactive oxygen species (ROS). SC attenuated UVB-induced oxidative macromolecular damage, including the protein carbonyl content, DNA strand break, and 8-isoprostane level. Furthermore, SC decreased UVB-induced Bax, cleaved caspase-9, and cleaved caspase-3 protein levels, but increased that of Bcl-2, which are well-known key mediators of apoptosis. Moreover, SC increased superoxide dismutase, catalase, and heme oxygenase-1 protein expression. Pre-treatment with SC upregulated the main transcription factor of antioxidant enzymes, erythroid 2-related factor 2 level, which was reduced by UVB irradiation. Extracellular signal-regulated kinase (ERK) and Jun N-terminal kinases (JNK) are involved in the regulation of many cellular events, including apoptosis. SC treatment reversed ERK and JNK activation induced by UVB. Collectively, these data indicate that SC can provide remarkable cytoprotection against the adverse effects of UVB radiation by modulating cellular antioxidant systems, and suggest the potential of developing a medical agent for ROS-induced skin diseases.


Subject(s)
Benzopyrans/pharmacology , Keratinocytes/radiation effects , Sunscreening Agents/pharmacology , Ultraviolet Rays , Caspase 3/metabolism , Caspase 9/metabolism , Catalase/metabolism , Cytoprotection , Extracellular Signal-Regulated MAP Kinases/metabolism , Humans , Keratinocytes/physiology , Reactive Oxygen Species/metabolism , Superoxide Dismutase/metabolism
6.
J Environ Pathol Toxicol Oncol ; 34(3): 191-200, 2015.
Article in English | MEDLINE | ID: mdl-26349602

ABSTRACT

In this study, we evaluated the hypothesis that a marine brown algae, Dictyopteris undulata ethanol extract (DUE), provokes apoptosis in a human melanoma cell line, A2058, via reactive oxygen species (ROS) and endoplasmic reticulum (ER) stress. DUE inhibited A2058 cell proliferation and increased apoptotic body formation, as indicated by the presence of fragmented nuclei and the activation of caspase-3. Moreover, DUE-treated cells showed elevated ER staining, mitochondrial calcium cation (Ca2+) overloading, augmented levels of ER stress-related and cell death modulatory proteins, including RNA-dependent protein kinase-related ER kinase, phospho-inositol-requiring enzyme 1α, phospho-eukaryotic translation initiation factor 2α, and CCAAT/enhancer-binding protein-homologous protein, as well as increased intracellular ROS levels. However, the antioxidant N-acetyl cysteine reversed the elevated ROS levels, decreased apoptosis, and mitigated ER stress in A2058 cells following DUE treatment. These findings suggest that DUE treatment triggers apoptosis in human melanoma cells through a mechanism involving ER stress and ROS.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Endoplasmic Reticulum Stress/drug effects , Phaeophyceae/chemistry , Reactive Oxygen Species/metabolism , Cell Line, Tumor , Humans
7.
Biomol Ther (Seoul) ; 23(3): 238-44, 2015 May.
Article in English | MEDLINE | ID: mdl-25995822

ABSTRACT

Macrophage-derived chemokine, C-C motif chemokine 22 (MDC/CCL22), is one of the inflammatory chemokines that controls the movement of monocytes, monocyte-derived dendritic cells, and natural killer cells. Serum and skin MDC/CCL22 levels are elevated in atopic dermatitis, which suggests that the chemokines produced from keratinocytes are responsible for attracting inflammatory lymphocytes to the skin. A major signaling pathway in the interferon-γ (IFN-γ)-stimulated inflammation response involves the signal transducers and activators of transcription 1 (STAT1). In the present study, we investigated the anti-inflammatory effect of dieckol and its possible action mechanisms in the category of skin inflammation including atopic dermatitis. Dieckol inhibited MDC/CCL22 production induced by IFN-γ (10 ng/mL) in a dose dependent manner. Dieckol (5 and 10 µM) suppressed the phosphorylation and the nuclear translocation of STAT1. These results suggest that dieckol exhibits anti-inflammatory effect via the down-regulation of STAT1 activation.

8.
Mar Drugs ; 13(4): 2141-57, 2015 Apr 13.
Article in English | MEDLINE | ID: mdl-25871292

ABSTRACT

Diphlorethohydroxycarmalol (DPHC) is a phlorotannin compound isolated from Ishige okamuarae, a brown alga. This study was conducted to investigate the anti-inflammatory effect and action mechanism of DPHC in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages. We found that DPHC strongly reduces the production of interleukin 6 (IL-6), but not that of tumor necrosis factor-alpha (TNF-α) induced by LPS. DPHC (12.5 and 100 µM) suppressed the phosphorylation and the nuclear translocation of NF-kappaB (NF-κB), a central signaling molecule in the inflammation process induced by LPS. The suppressor of cytokine signaling 1 (SOCS1) is a negative feedback regulator of Janus kinase (Jak)-signal transducer and activator of transcription (STAT) signaling. In this study, DPHC inhibited STAT5 expression and upregulated that of SOCS1 at a concentration of 100 µM. Furthermore, N-tosyl-l-phenylalanine chloromethyl ketone (TPCK) (a specific NF-κB inhibitor) and JI (a specific Jak2 inhibitor) reduced the production of IL-6, but not that of tumor necrosis factor-alpha (TNF-α) in LPS-stimulated RAW 264.7 macrophages. These findings demonstrate that DPHC inhibits IL-6 production via the downregulation of NF-κB and Jak2-STAT5 pathway and upregulation of SOCS1.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Heterocyclic Compounds, 3-Ring/pharmacology , Interleukin-6/antagonists & inhibitors , Macrophages/drug effects , NF-kappa B/antagonists & inhibitors , STAT5 Transcription Factor/antagonists & inhibitors , Suppressor of Cytokine Signaling Proteins/agonists , Administration, Cutaneous , Animals , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/isolation & purification , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Dermatitis, Atopic/immunology , Dermatitis, Atopic/pathology , Dermatitis, Atopic/prevention & control , Dose-Response Relationship, Drug , Female , Gene Expression Regulation/drug effects , Heterocyclic Compounds, 3-Ring/administration & dosage , Heterocyclic Compounds, 3-Ring/isolation & purification , Heterocyclic Compounds, 3-Ring/therapeutic use , Interleukin-6/metabolism , Lipopolysaccharides/antagonists & inhibitors , Lipopolysaccharides/toxicity , Macrophages/immunology , Macrophages/metabolism , Mice , Mice, Inbred BALB C , NF-kappa B/metabolism , Pacific Ocean , Phaeophyceae/chemistry , Phaeophyceae/growth & development , RAW 264.7 Cells , Republic of Korea , STAT5 Transcription Factor/genetics , STAT5 Transcription Factor/metabolism , Skin/drug effects , Skin/immunology , Skin/pathology , Specific Pathogen-Free Organisms , Suppressor of Cytokine Signaling 1 Protein , Suppressor of Cytokine Signaling Proteins/antagonists & inhibitors , Suppressor of Cytokine Signaling Proteins/genetics , Suppressor of Cytokine Signaling Proteins/metabolism
9.
J Biol Chem ; 289(46): 32044-32055, 2014 Nov 14.
Article in English | MEDLINE | ID: mdl-25301944

ABSTRACT

The endoplasmic reticulum (ER) has two membrane-bound acetyltransferases responsible for the endoluminal N(ϵ)-lysine acetylation of ER-transiting and -resident proteins. Mutations that impair the ER-based acetylation machinery are associated with developmental defects and a familial form of spastic paraplegia. Deficient ER acetylation in the mouse leads to defects of the immune and nervous system. Here, we report that both ATase1 and ATase2 form homo- and heterodimers and associate with members of the oligosaccharyltransferase (OST) complex. In contrast to the OST, the ATases only modify correctly folded polypetides. Collectively, our studies suggest that one of the functions of the ATases is to work in concert with the OST and "select" correctly folded from unfolded/misfolded transiting polypeptides.


Subject(s)
Acetyltransferases/chemistry , Endoplasmic Reticulum/enzymology , Hexosyltransferases/chemistry , Membrane Proteins/chemistry , Peptides/chemistry , Acetylation , Animals , Bacillus anthracis/enzymology , Bacillus subtilis/enzymology , Base Sequence , Escherichia coli/enzymology , Glycoproteins/chemistry , Humans , Lysine/chemistry , Mice , Models, Molecular , Molecular Sequence Data , Protein Binding , Protein Denaturation , Protein Folding , Protein Multimerization , Protein Structure, Tertiary , Salmonella enteritidis/enzymology
10.
Pharm Biol ; 52(9): 1110-8, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24617288

ABSTRACT

CONTEXT: Our previous work demonstrated that an ethyl acetate extract derived from Sargassum muticum (Yendo) Fenshol (SME) protected human HaCaT keratinocytes against ultraviolet B (UVB)-induced oxidative stress by increasing antioxidant activity in the cells, thereby inhibiting apoptosis. OBJECTIVE: The aim of the current study was to further elucidate the anti-apoptotic mechanism of SME against UVB-induced cell damage. MATERIALS AND METHODS: The expression levels of several apoptotic-associated and mitogen-activated kinase (MAPK) signaling proteins were determined by western blot analysis of UVB-irradiated HaCaT cells with or without prior SME treatment. In addition, the loss of mitochondrial membrane potential (Δψm) was detected using flow cytometry or confocal microscopy and the mitochondria membrane-permeate dye, JC-1. Apoptosis was assessed by quantifying DNA fragmentation and apoptotic body formation. Furthermore, cell viability was evaluated using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. RESULTS: SME absorbed electromagnetic radiation in the UVB range (280-320 nm) of the UV/visible light spectrum. SME also increased Bcl-2 and Mcl-1 expression in UVB-irradiated cells and decreased the Bax expression. Moreover, SME inhibited the UVB-induced disruption of mitochondrial membrane potential and prevented UVB-mediated increases in activated caspase-9 and caspase-3 (an apoptotic initiator and executor, respectively) levels. Notably, treatment with a pan-caspase inhibitor enhanced the anti-apoptotic effects of SME in UVB-irradiated cells. Finally, SME reduced the UVB-mediated phosphorylation of p38 MAPK and JNK, and prevented the UVB-mediated dephosphorylation of Erk1/2 and Akt. DISCUSSION AND CONCLUSION: The present results indicate that SME safeguards HaCaT keratinocytes from UVB-mediated apoptosis by inhibiting a caspase-dependent signaling pathway.


Subject(s)
Apoptosis/drug effects , Keratinocytes/drug effects , Plant Extracts/pharmacology , Sargassum/chemistry , Acetates/chemistry , Apoptosis/radiation effects , Caspase 3/metabolism , Caspase 9/metabolism , Cell Line , Cell Survival/drug effects , DNA Fragmentation/drug effects , DNA Fragmentation/radiation effects , Flow Cytometry , Humans , Keratinocytes/metabolism , Keratinocytes/radiation effects , MAP Kinase Signaling System/drug effects , Microscopy, Confocal , Phosphorylation/drug effects , Signal Transduction/drug effects , Ultraviolet Rays/adverse effects
11.
Appl Biochem Biotechnol ; 172(5): 2582-92, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24414942

ABSTRACT

The aim of the present study was to elucidate the protective properties of 3,4-dihydroxybenzoic acid (DBA) isolated from Cladophora wrightiana Harvey (a green alga) against ultraviolet B (UVB)-induced damage to human HaCaT keratinocytes. DBA exhibited scavenging actions against the 1,1-diphenyl-2-picrylhydrazyl radical, the superoxide anion, and the hydroxyl radical. Furthermore, DBA decreased the levels of intracellular reactive oxygen species generated by hydrogen peroxide or UVB treatment of the cells. DBA also decreased the UVB-augmented levels of phospho-histone H2A.X and the extent of comet tail formation, which are both indications of DNA damage. In addition, the compound safeguarded keratinocytes from UVB-induced injury by reversing the production of apoptotic bodies, overturning the disruption of mitochondrial membrane potential, increasing the expression of the anti-apoptotic protein, B-cell lymphoma 2, and decreasing the expression of the pro-apoptotic proteins, Bcl-2-associated X and cleaved caspase-3. Taken together, these results demonstrate that DBA isolated from a green alga protects human keratinocytes against UVB-induced oxidative stress and apoptosis.


Subject(s)
Free Radical Scavengers/pharmacology , Hydroxybenzoates/pharmacology , Keratinocytes/drug effects , Radiation-Protective Agents/pharmacology , Apoptosis/drug effects , Apoptosis/radiation effects , Biphenyl Compounds/antagonists & inhibitors , Biphenyl Compounds/metabolism , Caspase 3/genetics , Caspase 3/metabolism , Cell Line, Transformed , Chlorophyta/chemistry , DNA Fragmentation/drug effects , DNA Fragmentation/radiation effects , Free Radical Scavengers/isolation & purification , Gene Expression/drug effects , Histones/genetics , Histones/metabolism , Humans , Hydrogen Peroxide/pharmacology , Hydroxybenzoates/isolation & purification , Hydroxyl Radical/antagonists & inhibitors , Hydroxyl Radical/metabolism , Keratinocytes/cytology , Keratinocytes/metabolism , Keratinocytes/radiation effects , Membrane Potential, Mitochondrial/drug effects , Membrane Potential, Mitochondrial/radiation effects , Picrates/antagonists & inhibitors , Picrates/metabolism , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins c-bcl-2/metabolism , Radiation-Protective Agents/isolation & purification , Superoxides/antagonists & inhibitors , Superoxides/metabolism , Ultraviolet Rays
12.
Aging Cell ; 13(3): 449-56, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24341977

ABSTRACT

p44 is a short isoform of p53 with 'longevity-assurance' activity. Overexpression of p44 in the mouse (p44(+/+) transgenic mice) causes a progeroid phenotype that mimics an accelerated form of aging. The phenotype includes abnormal phosphorylation of the microtubule-binding protein tau, synaptic deficits, and cognitive decline. Genetic engineering demonstrated that the phosphorylation status of tau acts upstream of the synaptic deficits. Here, we provide evidence that p44 promotes the phosphorylation of tau in the mouse. Specifically, we show that p44 binds to the promoter of tau kinases Dyrk1A, GSK3ß, Cdk5, p35, and p39 and activates their transcription. The upregulation of the above kinases is followed by increased phosphorylation of tau. Finally, we show that p44 is preferentially found in the nucleus and that its levels increase with age in the mouse brain. Taken together, these results suggest that an imbalance in the p53:p44 ratio might be involved with the altered tau metabolism that characterizes aging.


Subject(s)
Alzheimer Disease/metabolism , Peptide Fragments/metabolism , Tumor Suppressor Protein p53/metabolism , tau Proteins/metabolism , Age Factors , Animals , Mice , Mice, Transgenic , Phosphorylation , Protein Isoforms , Signal Transduction , Transcription Factors
13.
Mar Drugs ; 11(9): 3272-87, 2013 Aug 27.
Article in English | MEDLINE | ID: mdl-23985898

ABSTRACT

Sargassum muticum (S. muticum) is a brown edible alga and widely distributed in Korea. This report was designed to evaluate the anti-inflammatory properties of apo-9'-fucoxanthinone (APO-9') isolated from S. muticum on pro-inflammatory cytokine production. S. muticum extract (SME) exhibited significant inhibitory effects on pro-inflammatory cytokine production in bone marrow-derived macrophages (BMDMs) and dendritic cells (BMDCs). APO-9' pre-treatment in the CpG DNA-stimulated BMDMs and BMDCs showed a strong dose-dependent inhibitory effect on interleukin (IL)-12 p40, IL-6 and tumor necrosis factor (TNF)-α production with IC50 values ranging from 5.31 to 13.79. It exhibited a strong inhibitory effect on the phosphorylation of ERK1/2 and on activator protein (AP)-1 reporter activity. APO-9' pre-treatment exhibited significant inhibition of CpG DNA-induced production of inducible nitric oxide synthase. Taken together, these data suggest that SME and APO-9' have a significant anti-inflammatory property and warrant further studies concerning the potentials of SME and APO-9' for medicinal use.


Subject(s)
Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/pharmacology , Plant Extracts/chemistry , Plant Extracts/pharmacology , Sargassum/chemistry , Animals , Cell Line , CpG Islands/drug effects , HEK293 Cells , Humans , I-kappa B Proteins/metabolism , Interleukin-2/metabolism , Interleukin-6/metabolism , Macrophages/drug effects , Macrophages/metabolism , Mice , Mitogen-Activated Protein Kinases , NF-KappaB Inhibitor alpha , NF-kappa B/metabolism , Nitric Oxide Synthase Type II/metabolism , Phaeophyceae/chemistry , Phosphorylation/drug effects , Signal Transduction/drug effects , Transcription Factor AP-1/metabolism
14.
J Biosci Bioeng ; 116(2): 256-64, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23474096

ABSTRACT

Chronic exposure of the skin to ultraviolet B (UVB) radiation induces oxidative stress, which plays a crucial role in the induction of skin cancer. The brown alga Undaria crenata is a potential source of antioxidant and anti-apoptotic compounds due to its capacity to produce protective compounds against environmental factors, including UV radiation. The aim of this study was to investigate the photoprotective properties of an U. crenata ethanol extract (UCE) against UVB-induced cell damage in human HaCaT keratinocytes. UCE exhibited absorbing effect of UVB (280-320 nm) and scavenging activity against the 1,1-diphenyl-2-picrylhydrazyl radical and intracellular reactive oxygen species induced by hydrogen peroxide and UVB rays. Furthermore, electron spin resonance spectrometry revealed the significant scavenging effect of UCE against superoxide anion and hydroxyl radical. UCE reduced UVB-induced apoptosis, as shown by a decrease in apoptotic bodies and nuclear and DNA fragmentation, resulting in the recovery of cell viability. UCE also decreased the degree of UVB-induced oxidative stress to lipids, proteins, and DNA as shown by a decrease in 8-isoprostane level, protein carbonylation and DNA tails. These results suggest that UCE protects human keratinocytes against UVB-induced oxidative stress.


Subject(s)
Keratinocytes/radiation effects , Oxidative Stress , Ultraviolet Rays , Undaria , Apoptosis/drug effects , Apoptosis/radiation effects , Cells, Cultured , Complex Mixtures/pharmacology , DNA Damage/drug effects , DNA Fragmentation/drug effects , Dinoprost/analogs & derivatives , Free Radical Scavengers/pharmacology , Humans , Keratinocytes/drug effects , Keratinocytes/metabolism , Lipid Peroxidation/drug effects , Oxidative Stress/drug effects , Protein Carbonylation/drug effects
15.
Mar Drugs ; 10(12): 2826-45, 2012 Dec 14.
Article in English | MEDLINE | ID: mdl-23242204

ABSTRACT

The present study investigated the photoprotective properties of an ethanol extract derived from the red alga Bonnemaisonia hamifera against ultraviolet B (UVB)-induced cell damage in human HaCaT keratinocytes. The Bonnemaisonia hamifera ethanol extract (BHE) scavenged the superoxide anion generated by the xanthine/xanthine oxidase system and the hydroxyl radical generated by the Fenton reaction (FeSO4 + H2O2), both of which were detected by using electron spin resonance spectrometry. In addition, BHE exhibited scavenging activity against the 1,1-diphenyl-2-picrylhydrazyl radical and intracellular reactive oxygen species (ROS) that were induced by either hydrogen peroxide or UVB radiation. BHE reduced UVB-induced apoptosis, as shown by decreased apoptotic body formation and DNA fragmentation. BHE also attenuated DNA damage and the elevated levels of 8-isoprostane and protein carbonyls resulting from UVB-mediated oxidative stress. Furthermore, BHE absorbed electromagnetic radiation in the UVB range (280-320 nm). These results suggest that BHE protects human HaCaT keratinocytes against UVB-induced oxidative damage by scavenging ROS and absorbing UVB photons, thereby reducing injury to cellular components.


Subject(s)
Free Radical Scavengers/pharmacology , Keratinocytes/drug effects , Rhodophyta/chemistry , Ultraviolet Rays/adverse effects , Apoptosis/drug effects , Apoptosis/radiation effects , Cell Line , DNA Fragmentation/drug effects , DNA Fragmentation/radiation effects , Electron Spin Resonance Spectroscopy , Ethanol/chemistry , Free Radical Scavengers/isolation & purification , Humans , Hydrogen Peroxide/toxicity , Keratinocytes/pathology , Keratinocytes/radiation effects , Oxidative Stress/drug effects , Oxidative Stress/radiation effects , Reactive Oxygen Species/metabolism , Superoxides/metabolism
16.
J Biol Chem ; 287(11): 8424-33, 2012 Mar 09.
Article in English | MEDLINE | ID: mdl-22267734

ABSTRACT

The cellular levels of ß-site APP cleaving enzyme 1 (BACE1), the rate-limiting enzyme for the generation of the Alzheimer disease (AD) amyloid ß-peptide (Aß), are tightly regulated by two ER-based acetyl-CoA:lysine acetyltransferases, ATase1 and ATase2. Here we report that both acetyltransferases are expressed in neurons and glial cells, and are up-regulated in the brain of AD patients. We also report the identification of first and second generation compounds that inhibit ATase1/ATase2 and down-regulate the expression levels as well as activity of BACE1. The mechanism of action involves competitive and non-competitive inhibition as well as generation of unstable intermediates of the ATases that undergo degradation.


Subject(s)
Acetyltransferases/metabolism , Alzheimer Disease/metabolism , Amyloid Precursor Protein Secretases/biosynthesis , Amyloid beta-Peptides/metabolism , Aspartic Acid Endopeptidases/biosynthesis , Gene Expression Regulation, Enzymologic , Neuroglia/metabolism , Neurons/metabolism , Acetyltransferases/antagonists & inhibitors , Acetyltransferases/genetics , Alzheimer Disease/drug therapy , Alzheimer Disease/genetics , Alzheimer Disease/pathology , Amyloid Precursor Protein Secretases/genetics , Amyloid beta-Peptides/genetics , Animals , Aspartic Acid Endopeptidases/genetics , CHO Cells , Cricetinae , Cricetulus , Enzyme Inhibitors/pharmacology , Humans , Mice , Mice, Transgenic , Neuroglia/pathology , Neurons/pathology , PC12 Cells , Rats , Up-Regulation/drug effects , Up-Regulation/genetics
17.
J Biol Chem ; 284(4): 2482-92, 2009 Jan 23.
Article in English | MEDLINE | ID: mdl-19011241

ABSTRACT

We have recently identified a novel form of post-translational regulation of BACE1 (beta-site amyloid precursor protein-cleaving enzyme 1), a membrane protein that acts as the rate-limiting enzyme in the generation of the Alzheimer disease amyloid beta-peptide. Specifically, nascent BACE1 is transiently acetylated in seven lysine residues clustered in a highly disordered region of the protein that faces the lumen of the endoplasmic reticulum (ER)/ER Golgi intermediate compartment (ER/ERGIC). The acetylation protects the nascent protein from degradation by PCSK9/NARC-1 in the ERGIC and allows it to reach the Golgi apparatus. Here we report the identification of two ER/ERGIC-based acetyltransferases, ATase1 and ATase2. Both proteins display acetyl-CoA:lysine acetyltransferase activity, can interact with and acetylate BACE1, and display an ER/ERGIC localization with the catalytic site facing the lumen of the organelle. Both ATase1 and ATase2 regulate the steady-state levels of BACE1 and the rate of amyloid beta-peptide generation. Finally, their transcripts are up-regulated by ceramide treatment. In conclusion, our studies have identified two new enzymes that may be involved in the pathogenesis of late-onset Alzheimer disease. The biochemical characterization of the above events could lead to the identification of novel pharmacological strategies for the prevention of this form of dementia.


Subject(s)
Acetyltransferases/metabolism , Amyloid Precursor Protein Secretases/metabolism , Aspartic Acid Endopeptidases/metabolism , Endoplasmic Reticulum/enzymology , Golgi Apparatus/enzymology , Protein Processing, Post-Translational , Acetyltransferases/chemistry , Acetyltransferases/genetics , Amyloid beta-Peptides/metabolism , Biocatalysis , Cell Line, Tumor , Ceramides/metabolism , Down-Regulation , Humans , Isoenzymes/chemistry , Isoenzymes/genetics , Isoenzymes/metabolism , Lysine/metabolism
18.
J Biol Chem ; 282(27): 19742-52, 2007 Jul 06.
Article in English | MEDLINE | ID: mdl-17485462

ABSTRACT

The sterol carrier protein SCP-x/pro-SCP-2 gene is a fusion gene having two initiation sites that generate a long (SCP-x; 58.9-kDa) and a short (pro-SCP-2; 15.4-kDa) product, both containing the common SCP-2 module at the C terminus. Here, we show that SCP-x is processed on the peroxisomal surface to liberate a short C-terminal product of 12.9 kDa. This fragment has DNA binding activity in vivo and in vitro, as assessed by chromatin immunoprecipitation analysis, DNA-protein pull-down, electrophoretic mobility shift assay, and luciferase reporter activity. In addition, it is preferentially found in the nucleus where it regulates the transcription of CD147, the regulatory subunit of the Alzheimer disease gamma-secretase. Overexpression of SCP-x increased, whereas antisense oligonucleotides against scp-x decreased, the generation of the above transcription factor. Both biochemical and genetic approaches indicate that pro-SCP-2 acts as a competitive inhibitor of SCP-x processing, thereby controlling the release of the 12.9-kDa transcriptionally active fragment. The transcription regulatory function of pro-SCP-2 requires a peroxisomal targeting sequence at the C terminus and a 20-amino acid leading sequence at the N terminus. Finally, pro-SCP-2 has also cholesterol carrier activity, which is functionally separated from the transcription regulatory one. In conclusion, we have identified two novel functions (transcriptional and transcription regulatory) of the SCP-x/pro-SCP-2 gene that have impact on gamma-secretase activity.


Subject(s)
Amyloid Precursor Protein Secretases/biosynthesis , Carrier Proteins/metabolism , Gene Expression Regulation, Enzymologic/physiology , Transcription, Genetic/physiology , Alzheimer Disease/enzymology , Alzheimer Disease/genetics , Amyloid Precursor Protein Secretases/genetics , Animals , Basigin/biosynthesis , Basigin/genetics , CHO Cells , Carrier Proteins/antagonists & inhibitors , Carrier Proteins/genetics , Cattle , Cricetinae , Cricetulus , Gene Expression Regulation, Enzymologic/drug effects , Humans , Oligonucleotides, Antisense/genetics , Oligonucleotides, Antisense/pharmacology , Peroxisomes/enzymology , Peroxisomes/genetics , Protein Processing, Post-Translational/drug effects , Protein Processing, Post-Translational/physiology , Protein Transport/drug effects , Protein Transport/physiology , Transcription, Genetic/drug effects
19.
Biochem J ; 407(3): 383-95, 2007 Nov 01.
Article in English | MEDLINE | ID: mdl-17425515

ABSTRACT

The lipid second messenger ceramide regulates the rate of beta cleavage of the Alzheimer's disease APP (amyloid precursor protein) by affecting the molecular stability of the beta secretase BACE1 (beta-site APP cleaving enzyme 1). Such an event is stimulated in the brain by the normal process of aging, and is under the control of the general aging programme mediated by the insulin-like growth factor 1 receptor. In the present study we report that BACE1 is acetylated on seven lysine residues of the N-terminal portion of the nascent protein. This process involves lysine acetylation in the lumen of the ER (endoplasmic reticulum) and is followed by deacetylation in the lumen of the Golgi apparatus, once the protein is fully mature. We also show that specific enzymatic activities acetylate (in the ER) and deacetylate (in the Golgi apparatus) the lysine residues. This process requires carrier-mediated translocation of acetyl-CoA into the ER lumen and is stimulated by ceramide. Site-directed mutagenesis indicates that lysine acetylation is necessary for nascent BACE1 to leave the ER and move ahead in the secretory pathway, and for the molecular stabilization of the protein.


Subject(s)
Amyloid Precursor Protein Secretases/metabolism , Aspartic Acid Endopeptidases/metabolism , Endoplasmic Reticulum/enzymology , Golgi Apparatus/enzymology , Lysine/metabolism , Acetylation , Amino Acid Sequence , Amyloid Precursor Protein Secretases/genetics , Animals , Aspartic Acid Endopeptidases/genetics , CHO Cells , Cricetinae , Cricetulus , Endoplasmic Reticulum/genetics , Endoplasmic Reticulum/metabolism , Enzyme Stability/genetics , Golgi Apparatus/genetics , Golgi Apparatus/metabolism , Humans , Lysine/genetics , Lysine/physiology , Molecular Sequence Data , Mutagenesis, Site-Directed , Protein Transport/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...